These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 8566556)

  • 21. [Hepatitis A-, B- and C-markers among Norwegian drug addicts in the period 1975-89].
    Kielland KB; Siebke JC
    Tidsskr Nor Laegeforen; 1991 Mar; 111(7):821-4. PubMed ID: 1902331
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Seroepidemiology of hepatitis B, delta and human immunodeficiency virus infections in Hamadan province, Iran: a population based study.
    Amini S; Mahmoodi MF; Andalibi S; Solati AA
    J Trop Med Hyg; 1993 Oct; 96(5):277-87. PubMed ID: 8411302
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Prevalence of antibodies to hepatitis A, hepatitis B and hepatitis C viruses in the German population].
    Thierfelder W; Meisel H; Schreier E; Dortschy R
    Gesundheitswesen; 1999 Dec; 61 Spec No():S110-4. PubMed ID: 10726407
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatitis C virus, alcoholic cirrhosis, and hepatocellular carcinoma.
    Goeser T; Müller HM; Solbach C; Toex U; Kommerell B; Theilmann L
    Cancer Epidemiol Biomarkers Prev; 1994 Jun; 3(4):311-5. PubMed ID: 8061579
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Does hepatitis C contribute to liver injury in alcohol abusers in the west of Scotland?
    Bird GL; Tibbs CJ; Orton D; Hillan KJ; MacSween RN; Williams R; Mills PR
    Eur J Gastroenterol Hepatol; 1995 Feb; 7(2):161-3. PubMed ID: 7536113
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antibody to hepatitis C is common among patients with alcoholic liver disease with and without risk factors.
    Caldwell SH; Jeffers LJ; Ditomaso A; Millar A; Clark RM; Rabassa A; Reddy KR; De Medina M; Schiff ER
    Am J Gastroenterol; 1991 Sep; 86(9):1219-23. PubMed ID: 1652885
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human T-lymphotropic virus type-I, and hepatitis A, B and C viruses in Nepal: a serological survey.
    Nakashima K; Kashiwagi S; Noguchi A; Hirata M; Hayashi J; Kawasaki T; Uezono K; Itoh K; Acharya GP; Ogata M
    J Trop Med Hyg; 1995 Oct; 98(5):347-50. PubMed ID: 7563265
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Viral hepatitis in Bucharest.
    Paquet C; Babes VT; Drucker J; Sénémaud B; Dobrescu A
    Bull World Health Organ; 1993; 71(6):781-6. PubMed ID: 8313496
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Susceptibility to hepatitis A virus infection among chronic liver disease patients and healthy blood donors in Thailand.
    Pramoolsinsap C; Attamasirul K; Busagorn N; Maneerat Y; Nuchprayoon C; Tanprasert S; Srivatanakul P; Theamboonlers A; Hirsch P; Poovorawan Y
    Southeast Asian J Trop Med Public Health; 1999 Mar; 30(1):91-5. PubMed ID: 10695795
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evidence of multiple hepatitis virus infections in autopsied materials of intravenous drug addicts.
    Schleicher S; Schieffer M; Jürgens S; Wehner HD; Flehmig B
    Ig Sanita Pubbl; 2005; 61(5):435-50. PubMed ID: 17214028
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The significance of anti-HBc and occult hepatitis B virus infection in the occurrence of hepatocellular carcinoma in patients with HBsAg and anti-HCV negative alcoholic cirrhosis].
    Kim MJ; Kwon OS; Chung NS; Lee SY; Jung HS; Park DK; Ku YS; Kim YK; Kim YS; Kim JH
    Korean J Hepatol; 2008 Mar; 14(1):67-76. PubMed ID: 18367859
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatitis B, C and Delta virus infections in Albanian patients with chronic liver disease: evaluation of possible changes during the last 10 years.
    Kondili LA; Cuko L; Chionne P; Candido A; Madonna E; Dentico P; Resuli B; Taliani G; Brunetto MR; Rapicetta M
    Eur J Gastroenterol Hepatol; 2010 Feb; 22(2):167-71. PubMed ID: 19734797
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Hepatitis B virus, serological markers of viral infections and humoral immunity in alcoholic cirrhosis].
    Vetter D; Doffoël M; Gut JP; Doffoël S; North ML; Charrault A; Ventre G; Mayer S; Bockel R
    Gastroenterol Clin Biol; 1985 May; 9(5):389-95. PubMed ID: 2989068
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence of hepatitis A, B, C, and E antibody in flying airline personnel.
    Andenaes S; Lie A; Degré M
    Aviat Space Environ Med; 2000 Dec; 71(12):1178-80. PubMed ID: 11439715
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epidemiology of hepatitis A and hepatitis E infection and their determinants in adult Chinese community in Hong Kong.
    Wong KH; Liu YM; Ng PS; Young BW; Lee SS
    J Med Virol; 2004 Apr; 72(4):538-44. PubMed ID: 14981755
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Viral hepatitis in South African healthcare workers at increased risk of occupational exposure to blood-borne viruses.
    Vardas E; Ross MH; Sharp G; McAnerney J; Sim J
    J Hosp Infect; 2002 Jan; 50(1):6-12. PubMed ID: 11825045
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Prevalence of HLA-A and -B antigens, anti-HBc and -HBs antibodies in alcoholic hepatopathies].
    Doffoël M; Tongio MM; Ledig M; Charrault A; Vetter D; North ML; Mayer S; Mandel P; Bockel R
    Ann Med Interne (Paris); 1985; 136(3):225-8. PubMed ID: 3875304
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence of viral markers among refugees from southern Albania: increased incidence of infection with hepatitis A, B and D viruses.
    Dalekos GN; Zervou E; Karabini F; Tsianos EV
    Eur J Gastroenterol Hepatol; 1995 Jun; 7(6):553-8. PubMed ID: 7552639
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antibodies to hepatitis C virus: a cross-sectional study in patients attending a trauma unit or admitted to hospital for elective surgery.
    García-Bengoechea M; Emparanza JI; Sarriugarte A; Cortés A; Vega JL; González F; Arenas JI
    Eur J Gastroenterol Hepatol; 1995 Mar; 7(3):237-41. PubMed ID: 7538032
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence and outcomes of HBV and anti-HCV seropositive patients with chronic liver disease and hepatocellular carcinoma.
    Pramoolsinsap C; Sumalnop K; Busagorn N; Kurathong S
    Southeast Asian J Trop Med Public Health; 1992 Mar; 23(1):6-11. PubMed ID: 1326124
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.